BioDelivery Sciences International
Corporate Headquarters
801 Corporate Center Drive, Suite 210
Raleigh, NC 27607
Tel: 919 582 9050
Fax: 919 582 9051
Business Development
BioDelivery Sciences is actively seeking partners interested in the BioErodible MucoAdhesive (BEMA) drug delivery technology and our product pipeline. BDSI has numerous established partnerships worldwide and continues to look for other companies interested in novel products or drug delivery technologies. We are currently looking for companies interested in the following:
- Collaborations to utilize our proven BEMA technology for delivery of existing marketed compounds, whether to enhance drug delivery properties, provide market differentiation or develop life cycle opportunities.
- Partner for commercialization of BEMA Buprenorphine/Naloxone (BNX) outside the U.S.
BDSI is also interested in opportunities to in-license late-stage or marketed products in the U.S. in the areas of CNS - including pain, psychiatry and addiction.
Business Development Contact
Al Medwar
801 Corporate Center Drive, Suite 210
Raleigh, NC 27607
Tel: 919 582 9050
Fax: 919 582 9051